Retrieve available abstracts of 94 articles: HTML format
Single Articles
June 2025
DAKIK HA Aspiration Thrombectomy for Coronary Stent Thrombosis.
N Engl J Med. 2025;392:e52. PubMed
May 2025
JOLLY SS, d'Entremont MA, Mian R Colchicine and Spironolactone in Acute Myocardial Infarction. Reply.
N Engl J Med. 2025;392:2075. PubMed
JOLLY SS, d'Entremont MA, Lee SF Colchicine and Spironolactone in Acute Myocardial Infarction. Reply.
N Engl J Med. 2025;392:2074-2075. PubMed
GOLINO M, Van Tassell B, Abbate A Colchicine and Spironolactone in Acute Myocardial Infarction.
N Engl J Med. 2025;392:2073-2074. PubMed
KIDA Y Colchicine and Spironolactone in Acute Myocardial Infarction.
N Engl J Med. 2025;392:2073. PubMed
GU HQ, Jiang Y, Li H Colchicine and Spironolactone in Acute Myocardial Infarction.
N Engl J Med. 2025;392:2072-2073. PubMed
VAN TWIST DJL, Appelboom Y Colchicine and Spironolactone in Acute Myocardial Infarction.
N Engl J Med. 2025;392:2072. PubMed
STRIESSNIG J Colchicine and Spironolactone in Acute Myocardial Infarction.
N Engl J Med. 2025;392:2071-2072. PubMed
ZANNAD F Seeking Multiorgan Benefits with Cardiovascular-Kidney-Metabolic Drug Therapy.
N Engl J Med. 2025;392:2061-2062. PubMed
QIU Z, Li F, Sang H, Yuan G, et al Intravenous Tenecteplase before Thrombectomy in Stroke.
N Engl J Med. 2025 May 21. doi: 10.1056/NEJMoa2503867. PubMedAbstract available
NICHOLLS SJ, Nelson AJ, Ditmarsch M, Kastelein JJP, et al Safety and Efficacy of Obicetrapib in Patients at High Cardiovascular Risk.
N Engl J Med. 2025 May 7. doi: 10.1056/NEJMoa2415820. PubMedAbstract available
RADER DJ Targeting Lipoprotein(a) - the Next Frontier in Cardiovascular Disease.
N Engl J Med. 2025;392:1740-1742. PubMed
March 2025
MAGNUSSEN C, Alegre-Diaz J, Al-Nasser LA, Amouyel P, et al Global Effect of Cardiovascular Risk Factors on Lifetime Estimates.
N Engl J Med. 2025 Mar 30. doi: 10.1056/NEJMoa2415879. PubMedAbstract available
MCGUIRE DK, Marx N, Mulvagh SL, Deanfield JE, et al Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes.
N Engl J Med. 2025 Mar 29. doi: 10.1056/NEJMoa2501006. PubMedAbstract available
KOTANIDIS CP, Maron DJ, Jernberg T Beta-Blocker Therapy after Acute Myocardial Infarction - To Block or Not to
Block?
N Engl J Med. 2025;392:1234-1236. PubMed
February 2025
RIDKER PM, Buring JE Biomarkers and 30-Year Cardiovascular Outcomes in Women. Reply.
N Engl J Med. 2025;392:828. PubMed
PEI C, Zhang W, Huang J Biomarkers and 30-Year Cardiovascular Outcomes in Women.
N Engl J Med. 2025;392:828. PubMed
GUI C, Huang Y Biomarkers and 30-Year Cardiovascular Outcomes in Women.
N Engl J Med. 2025;392:827-828. PubMed
CHO MS, Nam GB, Park DW Edoxaban for Atrial Fibrillation and Stable Coronary Artery Disease. Reply.
N Engl J Med. 2025;392:826-827. PubMed
SHIMAZU Y Edoxaban for Atrial Fibrillation and Stable Coronary Artery Disease.
N Engl J Med. 2025;392:826. PubMed
GREMMEL T Edoxaban for Atrial Fibrillation and Stable Coronary Artery Disease.
N Engl J Med. 2025;392:826. PubMed
KAWAI T, Williams WW, Elias N, Fishman JA, et al Xenotransplantation of a Porcine Kidney for End-Stage Kidney Disease.
N Engl J Med. 2025 Feb 7. doi: 10.1056/NEJMoa2412747. PubMedAbstract available
January 2025
SILVAIN J, Vicaut E, Montalescot G Beta-Blockers after Myocardial Infarction. Reply.
N Engl J Med. 2025;392:100-101. PubMed
CHI KY, Nanna MG Beta-Blockers after Myocardial Infarction.
N Engl J Med. 2025;392:99. PubMed
GASOWSKI J, Perera I, Piotrowicz K Beta-Blockers after Myocardial Infarction.
N Engl J Med. 2025;392:99. PubMed
VAN VOLLENHOVEN RF Beta-Blockers after Myocardial Infarction.
N Engl J Med. 2025;392:99. PubMed
December 2024
PURI R The Art and Science of Managing Stable Coronary Artery Disease in Patients
Undergoing TAVI.
N Engl J Med. 2024;391:2267-2268. PubMed
SALEH Y, Rios S Spontaneous Coronary-Artery Dissection.
N Engl J Med. 2024;391:e54. PubMed
November 2024
FIORELLA D, Monteith SJ, Hanel R, Atchie B, et al Embolization of the Middle Meningeal Artery for Chronic Subdural Hematoma.
N Engl J Med. 2024 Nov 20. doi: 10.1056/NEJMoa2409845. PubMedAbstract available
JOLLY SS, d'Entremont MA, Lee SF, Mian R, et al Colchicine in Acute Myocardial Infarction.
N Engl J Med. 2024 Nov 17. doi: 10.1056/NEJMoa2405922. PubMedAbstract available
JOLLY SS, d'Entremont MA, Pitt B, Lee SF, et al Routine Spironolactone in Acute Myocardial Infarction.
N Engl J Med. 2024 Nov 17. doi: 10.1056/NEJMoa2405923. PubMedAbstract available
RUBIN EJ, Leopold J, Morrissey S NEJM at AHA - Routine Spironolactone in Acute Myocardial Infarction.
N Engl J Med. 2024 Nov 17. doi: 10.1056/NEJMe2414472. PubMed
SAPP JL, Tang ASL, Parkash R, Stevenson WG, et al Catheter Ablation or Antiarrhythmic Drugs for Ventricular Tachycardia.
N Engl J Med. 2024 Nov 16. doi: 10.1056/NEJMoa2409501. PubMedAbstract available
October 2024
HEATON K, Zern EK, Spahillari A, Barrett CD, et al Case 34-2024: A 69-Year-Old Man with Dyspnea after Old Myocardial Infarction.
N Engl J Med. 2024;391:1633-1641. PubMed
ALKAISSI H, Nazari MA, Hadrava Vanova K, Uher O, et al Rapid Cardiovascular Response to Belzutifan in HIF2A-Mediated Paraganglioma.
N Engl J Med. 2024;391:1552-1555. PubMed
JERNBERG T Routine Beta-Blockers in Secondary Prevention - Approaching Retirement?
N Engl J Med. 2024;391:1356-1357. PubMed
September 2024
HABIB M, Aronson D Electrocardiographic Findings in Diffuse Subendocardial Ischemia.
N Engl J Med. 2024;391:e19. PubMed
RUBIN EJ, Leopold J, Morrissey S NEJM at ESC - Invasive versus Conservative Strategy for Older Patients with
Myocardial Infarction.
N Engl J Med. 2024 Sep 1. doi: 10.1056/NEJMe2410900. PubMed
KUNADIAN V, Mossop H, Shields C, Bardgett M, et al Invasive Treatment Strategy for Older Patients with Myocardial Infarction.
N Engl J Med. 2024 Sep 1. doi: 10.1056/NEJMoa2407791. PubMedAbstract available
RUBIN EJ, Leopold J, Morrissey S NEJM at ESC - Edoxaban Antithrombotic Therapy for Atrial Fibrillation and Stable
Coronary Artery Disease.
N Engl J Med. 2024 Sep 1. doi: 10.1056/NEJMe2410903. PubMed
LIP GYH Atrial Fibrillation and Stable Coronary Artery Disease.
N Engl J Med. 2024 Sep 1. doi: 10.1056/NEJMe2409696. PubMed
CHO MS, Kang DY, Ahn JM, Yun SC, et al Edoxaban Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary
Artery Disease.
N Engl J Med. 2024 Sep 1. doi: 10.1056/NEJMoa2407362. PubMedAbstract available
August 2024
RUBIN EJ, Leopold J, Morrissey S NEJM at ESC - Inflammation, Cholesterol, Lipoprotein(a) and 30-Year
Cardiovascular Outcomes in Women.
N Engl J Med. 2024 Aug 31. doi: 10.1056/NEJMe2410895. PubMed
BLUMENTHAL RS, Martin SS Prevention of Cardiovascular Disease - Don't Stop Thinking about Tomorrow.
N Engl J Med. 2024 Aug 31. doi: 10.1056/NEJMe2409080. PubMed
RIDKER PM, Moorthy MV, Cook NR, Rifai N, et al Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in
Women.
N Engl J Med. 2024 Aug 31. doi: 10.1056/NEJMoa2405182. PubMedAbstract available
LONBORG J, Jabbari R, Sabbah M, Veien KT, et al PCI in Patients Undergoing Transcatheter Aortic-Valve Implantation.
N Engl J Med. 2024 Aug 31. doi: 10.1056/NEJMoa2401513. PubMedAbstract available
SILVAIN J, Cayla G, Ferrari E, Range G, et al Beta-Blocker Interruption or Continuation after Myocardial Infarction.
N Engl J Med. 2024 Aug 30. doi: 10.1056/NEJMoa2404204. PubMedAbstract available
RUBIN EJ, Leopold J, Morrissey S NEJM at ESC - Beta Blocker Interruption or Continuation with Prior Myocardial
Infarction.
N Engl J Med. 2024 Aug 30. doi: 10.1056/NEJMe2410891. PubMed
MAHENDIRAN T, Collet C, De Bruyne B More on Coronary-Artery Autoregulation with Increasing Stenosis. Reply.
N Engl J Med. 2024;391:671. PubMed
YANG X, Wu M, Zhang G More on Coronary-Artery Autoregulation with Increasing Stenosis.
N Engl J Med. 2024;391:670-671. PubMed
July 2024
BOHM F, James S FFR-Guided Complete or Culprit-Only PCI in Patients with Myocardial Infarction.
Reply.
N Engl J Med. 2024;391:288. PubMed
LI P FFR-Guided Complete or Culprit-Only PCI in Patients with Myocardial Infarction.
N Engl J Med. 2024;391:287-288. PubMed
YNDIGEGN T, Hofmann R, Jernberg T Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction. Reply.
N Engl J Med. 2024;391:95. PubMed
KOMAMURA K, Kobayashi K, Iwase M Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction.
N Engl J Med. 2024;391:94-95. PubMed
CLELAND JGF, McMurray JJV, Freemantle N Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction.
N Engl J Med. 2024;391:94. PubMed
June 2024
MOLLER JE, Hassager C Microaxial Flow Pump in Infarct-Related Cardiogenic Shock. Reply.
N Engl J Med. 2024;390:2328-2330. PubMed
VON LEWINSKI D, Herold L, Toth GG Microaxial Flow Pump in Infarct-Related Cardiogenic Shock.
N Engl J Med. 2024;390:2328. PubMed
BALDETTI L, Pieri M, Scandroglio AM Microaxial Flow Pump in Infarct-Related Cardiogenic Shock.
N Engl J Med. 2024;390:2328. PubMed
ELKARYONI A, Hyder O, Saad M Microaxial Flow Pump in Infarct-Related Cardiogenic Shock.
N Engl J Med. 2024;390:2327. PubMed
FROM AM Microaxial Flow Pump in Infarct-Related Cardiogenic Shock.
N Engl J Med. 2024;390:2327. PubMed
MALLIDI J, Lotfi A Microaxial Flow Pump in Infarct-Related Cardiogenic Shock.
N Engl J Med. 2024;390:2326-2327. PubMed
THIELE H, Desch S, Zeymer U Microaxial Flow Pump in Infarct-Related Cardiogenic Shock.
N Engl J Med. 2024;390:2325-2326. PubMed
MANRIQUE-ACEVEDO C, Hirsch IB, Eckel RH Prevention of Cardiovascular Disease in Type 1 Diabetes. Reply.
N Engl J Med. 2024;390:2227. PubMed
MAAHS DM, Svensson J Prevention of Cardiovascular Disease in Type 1 Diabetes.
N Engl J Med. 2024;390:2226-2227. PubMed
WENSTEDT EFE, Vogt L Prevention of Cardiovascular Disease in Type 1 Diabetes.
N Engl J Med. 2024;390:2226. PubMed
LI S, Gu HQ, Li H, Wang X, et al Reteplase versus Alteplase for Acute Ischemic Stroke.
N Engl J Med. 2024 Jun 14. doi: 10.1056/NEJMoa2400314. PubMedAbstract available
XIONG Y, Campbell BCV, Schwamm LH, Meng X, et al Tenecteplase for Ischemic Stroke at 4.5 to 24 Hours without Thrombectomy.
N Engl J Med. 2024 Jun 14. doi: 10.1056/NEJMoa2402980. PubMedAbstract available
MAHENDIRAN T, Collet C, De Bruyne B Coronary-Artery Autoregulation with Increasing Stenosis.
N Engl J Med. 2024;390:2030-2032. PubMed
May 2024
KING G, Hamilton GW Left Ventricular Thrombus after Anterior Myocardial Infarction.
N Engl J Med. 2024;390:e50. PubMed
NATARAJAN P Exceptional Genetics, Generalizable Therapeutics, and Coronary Artery Disease.
N Engl J Med. 2024 May 29. doi: 10.1056/NEJMe2405647. PubMed
ALBERS GW, Purdon B, Campbell BCV Tenecteplase for Stroke at 4.5 to 24 Hours. Reply.
N Engl J Med. 2024;390:1729. PubMed
GOYAL M, Bosshart SL, Ospel JM Tenecteplase for Stroke at 4.5 to 24 Hours.
N Engl J Med. 2024;390:1729. PubMed
GRINSPOON SK, Ribaudo HJ, Douglas PS Trial Update of Pitavastatin to Prevent Cardiovascular Events in HIV Infection.
N Engl J Med. 2024;390:1626-1628. PubMed
April 2024
STEG PG Routine Beta-Blockers in Secondary Prevention - On Injured Reserve.
N Engl J Med. 2024;390:1434-1436. PubMed
RAO SV Mechanical Circulatory Support in Cardiogenic Shock - Persistence and Progress.
N Engl J Med. 2024;390:1436-1438. PubMed
MOLLER JE, Engstrom T, Jensen LO, Eiskjaer H, et al Microaxial Flow Pump or Standard Care in Infarct-Related Cardiogenic Shock.
N Engl J Med. 2024;390:1382-1393. PubMedAbstract available
BOHM F, Mogensen B, Engstrom T, Stankovic G, et al FFR-Guided Complete or Culprit-Only PCI in Patients with Myocardial Infarction.
N Engl J Med. 2024 Apr 8. doi: 10.1056/NEJMoa2314149. PubMedAbstract available
KUNADIAN V Role of Physiology in the Management of Nonculprit Lesions in Acute Coronary
Syndrome.
N Engl J Med. 2024 Apr 8. doi: 10.1056/NEJMe2403527. PubMed
YNDIGEGN T, Lindahl B, Mars K, Alfredsson J, et al Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction.
N Engl J Med. 2024 Apr 7. doi: 10.1056/NEJMoa2401479. PubMedAbstract available
BERGMARK BA, Marston NA, Prohaska TA, Alexander VJ, et al Olezarsen for Hypertriglyceridemia in Patients at High Cardiovascular Risk.
N Engl J Med. 2024 Apr 7. doi: 10.1056/NEJMoa2402309. PubMedAbstract available
GIBSON CM, Duffy D, Korjian S, Bahit MC, et al Apolipoprotein A1 Infusions and Cardiovascular Outcomes after Acute Myocardial
Infarction.
N Engl J Med. 2024 Apr 6. doi: 10.1056/NEJMoa2400969. PubMedAbstract available
ROULEAU J Decreasing the Risk of Heart Failure in a Changing Post-Myocardial Infarction
Environment.
N Engl J Med. 2024 Apr 6. doi: 10.1056/NEJMe2402719. PubMed
BUTLER J, Jones WS, Udell JA, Anker SD, et al Empagliflozin after Acute Myocardial Infarction.
N Engl J Med. 2024 Apr 6. doi: 10.1056/NEJMoa2314051. PubMedAbstract available
MANRIQUE-ACEVEDO C, Hirsch IB, Eckel RH Prevention of Cardiovascular Disease in Type 1 Diabetes.
N Engl J Med. 2024;390:1207-1217. PubMed
March 2024
WHITE HD A Placebo-Controlled Trial of PCI for Stable Angina. Reply.
N Engl J Med. 2024;390:10. PubMed
AL-LAMEE RK, Rajkumar CA A Placebo-Controlled Trial of PCI for Stable Angina. Reply.
N Engl J Med. 2024;390:1151-1152. PubMed
DURANTE A, Baiardo Redaelli M A Placebo-Controlled Trial of PCI for Stable Angina.
N Engl J Med. 2024;390:1150-1151. PubMed
SHERROD CF 4TH, O'Keefe EL, Ikemura N A Placebo-Controlled Trial of PCI for Stable Angina.
N Engl J Med. 2024;390:1150. PubMed
BESTERMANN WH JR A Placebo-Controlled Trial of PCI for Stable Angina.
N Engl J Med. 2024;390:1149-1150. PubMed
ROSWELL RO, Wong MP, Stefanescu Schmidt AC, Petranovic M, et al Case 8-2024: A 55-Year-Old Man with Cardiac Arrest, Cardiogenic Shock, and
Hypoxemia.
N Engl J Med. 2024;390:1030-1043. PubMed
CARSON JL, Brooks MM, Hebert PC Transfusion Strategy in Myocardial Infarction and Anemia. Reply.
N Engl J Med. 2024;390:961-962. PubMed
KHAN MS, Spertus JA, Chan PS Transfusion Strategy in Myocardial Infarction and Anemia.
N Engl J Med. 2024;390:960-961. PubMed
CHAPALAIN X, Aubron C Transfusion Strategy in Myocardial Infarction and Anemia.
N Engl J Med. 2024;390:960. PubMed
MARFELLA R, Prattichizzo F, Sardu C, Fulgenzi G, et al Microplastics and Nanoplastics in Atheromas and Cardiovascular Events.
N Engl J Med. 2024;390:900-910. PubMedAbstract available